Abstract PO-003: Predictors for 30-day readmission in patients with pancreatic cancer who had DNR code status

Background: Pancreatic cancer is a lethal malignancy, and most patients present with advanced disease. There is little known about the 30-day readmission rate in patients with Do-not resuscitate (DNR) code status in pancreatic cancer. The study aims to look for predictors for 30-day readmission in pancreatic cancer patients with DNR code status. Methods: This is a retrospective study of a nationally representative cohort of hospitalized admissions admitted from January 1, 2016, to December 31, 2018; 240,107 index pancreatic cancer hospitalizations were recorded. The database was obtained from the Agency for Healthcare Research and Quality’s (AHRQ) Healthcare Cost and Utilization Project (HCUP) national readmission (NRD) dataset files between 2016 – 2018. We examined predictors of death and 30-day readmission among patients with pancreatic cancer who had DNR code status. We evaluated readmission in pancreatic cancer with DNR code status in multivariable Cox hazard regression models. Results: There were 240,107 index hospitalizations with pancreatic cancer (PAC) for the years 2016-2018. There were 51,451 (21.4%) PAC patients who had DNR code status during the index hospitalization. Patients with DNR status had a mean age of 68. The PAC patients with DNR status had significantly higher numbers of inpatient mortality (22% (DNR status) vs 3% (full code) (OR 4.24 (95% CI 3.9-4.6; P Citation Format: Jasmeet Kaur, Tanveer Mir, Paramveer Singh, Judie Goodman. Predictors for 30-day readmission in patients with pancreatic cancer who had DNR code status [abstract]. In: Proceedings of the AACR Virtual Special Conference on Pancreatic Cancer; 2021 Sep 29-30. Philadelphia (PA): AACR; Cancer Res 2021;81(22 Suppl):Abstract nr PO-003.